23andme Holding Co (ME) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
23andme Holding Co  (ME)

Select the Financial Report: Select the Period:


Description of 23andme Holding Co's Business Segments


23andMe Holding Co: Comprehensive Overview

23andMe Holding Co is a pioneering biotechnology and genetic testing company that focuses on empowering individuals to understand their genetic information, emphasizing health and ancestry insights. The company offers a multifaceted suite of segments, products, and services designed to cater to diverse consumer needs, along with support for research initiatives.

Segments

1. Health and Ancestry Reports:
- Ancestry + Traits Service: This segment enables customers to obtain a comprehensive ethnicity estimate derived from their DNA, offering insights into ancestral origins. Users can explore various ethnic group percentages and trace their lineage.
- Health Risk Reports: These reports provide vital information on genetic predispositions to certain health conditions. The service includes assessments for various genetic health risks, including but not limited to:
- Type 2 Diabetes
- Alzheimer’s Disease
- Parkinson’s Disease
- Certain types of cancer (e.g. breast and ovarian cancer)
- Carrier Status Reports: It helps individuals discover whether they are carriers of genetic mutations that could be passed on to their offspring, influencing decisions regarding family planning.

2. Genetic Counseling:
- This segment centers on offering support and guidance from certified genetic counselors to those who have received test results indicating potential health risks. Counselors assist customers in:
- Understanding test results, their implications, and the significance of genetic findings.
- Discussing further steps, including additional testing or preventive measures.
- Providing personalized advice on managing health risks and lifestyle choices.

Products

1. DNA Testing Kits:
- The flagship product is the DNA testing kit, which includes a saliva collection kit and precise instructions for users to collect their DNA sample. Once the sample is sent back, it undergoes analysis in a laboratory setting. The final results are delivered through an online platform, providing customers access to their genetic information efficiently.
- The DNA testing kits are user-friendly and designed to cater to a variety of age groups, making them accessible to a wide audience.

2. Research Services:
- 23andMe offers a unique research services segment allowing academic and commercial entities to collaborate with the company. Through their research partnerships, institutions can access anonymized genetic data collected via consumer testing. Utilizing this vast dataset, researchers can delve into:
- Population genetics
- Clinical studies
- Drug development processes
- This facet not only bolsters scientific research but also contributes to the larger body of knowledge regarding genetics and health.

Services

1. DNA Testing:
- Beyond the standard reporting that comes with DNA testing, the genetic testing service includes various features such as ethnic background estimation, connections to relatives who have also tested, as well as unique genetic traits (e.g. genetic markers linked to taste preferences).

2. Ancestry Reports:
- In-depth ancestry reports explore not just ethnic composition but also detailed genealogical information. Customers can gain insights into their family history, migration patterns of their ancestors, and even connections to historical populations.

3. Genetic Counseling:
- Following the analytical report, customers with concerning genetic markers can consult with 23andMes genetic counseling team. The service is aimed at offering clarity and support in managing genetic health risks and exploring familial repercussions.

4. Research Participation:
- Engaged customers are offered the chance to partake in research studies that seek to explore various health and genetic topics. By contributing their genetic material and health information, participants help advance the discovery of treatments and understanding of genetic diseases and conditions.

Conclusion

In summary, 23andMe Holding Co emerges as a multifaceted entity within the biotechnology and genetic testing landscape, offering an array of products and services tailored to empower individuals with knowledge about their genetic background and health. Through innovative segments such as health and ancestry reports, alongside professional counseling and research collaboration, the company stands at the forefront of genetic literacy, thereby enabling consumers to make well-informed decisions regarding their health and wellness.


Composition of 23andme Holding Co Revenues by Segments

 
PGS    78.04 % of total Revenue
PGS Point in Time    37.97 % of total Revenue
PGS Over Time    40.06 % of total Revenue
Telehealth    23.18 % of total Revenue
Telehealth Point in Time    17.41 % of total Revenue
Telehealth Over Time    5.77 % of total Revenue
Consumer services    71.75 % of total Revenue
Consumer services Point in Time    55.39 % of total Revenue
Consumer services Over Time    45.83 % of total Revenue
Research services    27.31 % of total Revenue
Research services Point in Time    0.76 % of total Revenue
Research services Over Time    1.65 % of total Revenue
Service    83.91 % of total Revenue
Service Point in Time    56.14 % of total Revenue
Service Over Time    47.48 % of total Revenue
United States    90.26 % of total Revenue
United Kingdom    5.67 % of total Revenue
Canada    5.3 % of total Revenue
Other regions    2.41 % of total Revenue
Research services Related Party    0.82 % of total Revenue

Q1 three months ended (Jun 30 2025)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
PGS 19.14 78.04 %
PGS Point in Time 9.32 37.97 %
PGS Over Time 9.83 40.06 %
Telehealth 5.69 23.18 %
Telehealth Point in Time 4.27 17.41 %
Telehealth Over Time 1.42 5.77 %
Consumer services 17.60 71.75 %
Consumer services Point in Time 13.59 55.39 %
Consumer services Over Time 11.24 45.83 %
Research services 6.70 27.31 %
Research services Point in Time 0.19 0.76 %
Research services Over Time 0.40 1.65 %
Service 20.58 83.91 %
Service Point in Time 13.77 56.14 %
Service Over Time 11.65 47.48 %
United States 22.14 90.26 %
United Kingdom 1.39 5.67 %
Canada 1.30 5.3 %
Other regions 0.59 2.41 %
Research services Related Party 0.20 0.82 %
Total 24.53 100 %




Q1 three months ended (Jun 30 2025)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
PGS -41.11 % -
PGS Point in Time -61.82 % -
PGS Over Time 21.19 % -
Telehealth -14.44 % -
Telehealth Point in Time -15.24 % -
Telehealth Over Time -11.94 % -
Consumer services -55.05 % -
Consumer services Point in Time -53.85 % -
Consumer services Over Time 15.7 % -
Research services 431.32 % -
Research services Point in Time -45.93 % -
Research services Over Time -55.94 % -
Service -40.64 % -
Service Point in Time -53.75 % -
Service Over Time 9.53 % -
United States -37.25 % -
United Kingdom -34.56 % -
Canada -35.53 % -
Other regions -40.4 % -
Research services Related Party - -
Total -37.92 % -87.02 %




Q1 three months ended (Jun 30 2025)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -23.83 -




Q1 three months ended (Jun 30 2025)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on 23andme Holding Co Divisions, Sales by Country

 
PGS   PGS Segment contribution to total sales 74.6 % of total Revenue
PGS Point in Time   PGS Point in Time Segment contribution to total sales 54.43 % of total Revenue
PGS Over Time   PGS Over Time Segment contribution to total sales 20.17 % of total Revenue
Telehealth   Telehealth Segment contribution to total sales 13.5 % of total Revenue
Telehealth Point in Time   Telehealth Point in Time Segment contribution to total sales 10.24 % of total Revenue
Telehealth Over Time   Telehealth Over Time Segment contribution to total sales 3.26 % of total Revenue
Consumer services   Consumer services Segment contribution to total sales 88.1 % of total Revenue
Consumer services Point in Time   Consumer services Point in Time Segment contribution to total sales 64.67 % of total Revenue
Consumer services Over Time   Consumer services Over Time Segment contribution to total sales 23.43 % of total Revenue
Research services   Research services Segment contribution to total sales 11.48 % of total Revenue
Research services Point in Time   Research services Point in Time Segment contribution to total sales 11.05 % of total Revenue
Research services Over Time   Research services Over Time Segment contribution to total sales 1.32 % of total Revenue
Service   Service Segment contribution to total sales 88.84 % of total Revenue
Service Point in Time   Service Point in Time Segment contribution to total sales 75.72 % of total Revenue
Service Over Time   Service Over Time Segment contribution to total sales 24.75 % of total Revenue
United States   United States Segment contribution to total sales 78.92 % of total Revenue
Canada   Canada Segment contribution to total sales 4.57 % of total Revenue
Other regions   Other regions Segment contribution to total sales 2.09 % of total Revenue
Research services Related Party   Research services Related Party Segment contribution to total sales 10.79 % of total Revenue
UK   UK Segment contribution to total sales 14.89 % of total Revenue


Twelve months ended 2025
ME s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
PGS 140.99 74.6 %
PGS Point in Time 102.87 54.43 %
PGS Over Time 38.12 20.17 %
Telehealth 25.52 13.5 %
Telehealth Point in Time 19.36 10.24 %
Telehealth Over Time 6.16 3.26 %
Consumer services 166.51 88.1 %
Consumer services Point in Time 122.23 64.67 %
Consumer services Over Time 44.28 23.43 %
Research services 21.70 11.48 %
Research services Point in Time 20.89 11.05 %
Research services Over Time 2.50 1.32 %
Service 167.91 88.84 %
Service Point in Time 143.11 75.72 %
Service Over Time 46.78 24.75 %
United States 149.16 78.92 %
Canada 8.64 4.57 %
Other regions 3.95 2.09 %
Research services Related Party 20.40 10.79 %
Total 189.00 100 %
UK 28.14 14.89 %


Twelve months ended 2025
ME s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -280.89 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
PGS -15.95 % -
PGS Point in Time -29.11 % -
PGS Over Time 68.44 % -
Telehealth -26.18 % -
Telehealth Point in Time -26.92 % -
Telehealth Over Time -23.76 % -
Consumer services -17.7 % -
Consumer services Point in Time -28.77 % -
Consumer services Over Time 44.18 % -
Research services 57.25 % -
Research services Point in Time 422.54 % -
Research services Over Time -81.23 % -
Service -12.46 % -
Service Point in Time -18.5 % -
Service Over Time 6.22 % -
United States -17.2 % -
Canada -18.18 % -
Other regions -14.78 % -
Research services Related Party 72.88 % -
UK 15.89 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.